2020 American Transplant Congress
Does Donor Terminal, Admission or Best Estimate Glomerular Filtration Rate Predicts Kidney Transplantation Outcomes
*Purpose: When assessing deceased kidney donors, a key factor is donor kidney function. It is unclear whether terminal, admission, or the best of terminal and…2020 American Transplant Congress
Trajectories of Glomerular Filtration Rate and Progression to End Stage Renal Disease after Kidney Transplantation
*Purpose: Although the current gold standard of monitoring kidney transplant function relies on glomerular filtration rate (GFR) assessment, little is known about GFR trajectories after…2020 American Transplant Congress
Successful Transplantation Outcomes Utilizing Deceased Donorswith Acute Kidney Injury
Kidney and Kidney/Pancreas Transplant, Miami Transplant Institute, Miami, FL
*Purpose: Kidneys from deceased donors with acute kidney injury (AKI) are discarded at a higher rate than those without AKI, exacerbating the organ shortage crisis.…2020 American Transplant Congress
Conversion to Belatacept in HIV(+) Renal Transplant Recipients
Mount Sinai Hospital, New York, NY
*Purpose: HIV(+) renal transplant recipients were excluded from phase III trials of belatacept, and currently there are only scattered case reports.*Methods: This was a single…2020 American Transplant Congress
Delayed Graft Function Adversely Affects Long-Term Survival for Kidney Recipients after Non-Renal Solid-Organ Transplantation
Surgery, University of Wisconsin, Madison, WI
*Purpose: End-stage renal disease (ESRD) frequently develops after nonrenal solid-organ transplantation, increasing the number of patients with a prior heart, liver or lung transplant on…2020 American Transplant Congress
Belatacept Conversion: Are Patients BENEFIT-ing
Columbia University Irving Medical Center, New York, NY
*Purpose: Belatacept is increasingly used in renal transplant recipients experiencing adverse effects from calcineurin inhibitors(CNI) despite limited medium- and long- term data on safety and…2020 American Transplant Congress
Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Therapy Prior to Kidney Transplantation Does Not Impact Recovery of Function
*Purpose: The impact of chronically administered medications for renin-angiotensin-aldosterone blockade (e.g. ACE-I, ARB), taken prior to kidney transplant (KTx), on immediate allograft function is unknown.*Methods:…2020 American Transplant Congress
Outcomes of Kidney Transplant Patients Evaluated, Listed and Managed Using A Distant Transplant Outreach Care Model (DTrOM)
*Purpose: All advanced kidney disease and post-transplant patients are not always fortunate enough to be living close to a transplant care center. To this end,…2020 American Transplant Congress
Metabolic Syndrome Predicts Worse Long-Term Renal Outcomes in Living Kidney Donors (LKDs)
1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Scottsdale, AZ
*Purpose: Prior studies linked metabolic syndrome with worse kidney outcomes in a variety of populations. In this study, we assessed the long-term risk of reduced…2020 American Transplant Congress
Trough Level Compliance in Immunosuppression is Important to Protect Renal Function after Liver Transplantation – An Additional Analysis from the Hephaistos Study
1Hephaistos, Study Group, Germany, 2Novartis Pharma GmbH, Nürnberg, Germany
*Purpose: Most immunosuppressive drugs are dosed according to trough levels (C0-levels). To achieve the optimal balance between efficacy and safety, it is important to avoid…
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- …
- 27
- Next Page »